Mingming Ma, President
Dr. Mingming Ma is the Principal Research Scientist in Crop Protection Regulatory Sciences, Corteva Agriscience. She has more than 15 years experiences in analytical and bioanalytical chemistry for both small and large molecules. She has 26 peer-reviewed journal publications and co-edited a book. Dr. Ma serves as an American Chemical Society - AGRO division executive committee since 2019.
Yi He, Immediate Past President
Dr. Yi He studied applied chemistry and environmental chemical engineering at Shanghai Jiao Tong University in China and analytical chemistry in National University of Singapore (NUS) before completing her Ph.D. in analytical chemistry in 2004 at the City University of New York (CUNY). She took a position as an Assistant Professorof Chemistry at John Jay College of Criminal Justice of CUNY in fall 2004 and was promoted to full professor in 2016.
Fengjian Shi, President-Elect
Dr. Fengjian Shi is a scientist in Analytical Development at Biogen. Prior to joining Biogen, Fengjian received his B.S. in Chemistry from Nanjing University in 2011 and PhD in Analytical Chemistry from Temple University in 2017.
Howard (HongYue) Guo, Treasurer
Howard (HongYue) Guo
Dr. Hongyue (Howard) Guo is a senior scientist in Drug Product Development at BMS. Prior to joining BMS, Howard has worked as an investigator in CMC analytical at GSK. Howard received Ph.D. degree in Analytical Chemistry from The University of Texas at Arlington in 2016.
Tao Chen, Secretary
Dr. Tao Chen received her Ph.D. in Analytical Chemistry from University of Florida in 2013. Her doctoral study under professor Weihong Tan explored the applications of aptamer-conjugated nanomaterials in cancer diagnostics and therapy. She then joined Small Molecule Pharmaceutical Sciences in Genentech, Inc. in 2014, where she has contributed to various projects ranging from antibody-drug conjugates to peptides and traditional small molecule drugs, with research interests in developing novel analytical and chromatographic techniques for characterization of new drug modalities.
Wu Chen, Committee Member
Working experience:
Agilent Technologies (from 1997 to current)
Column R&D, HPLC column expert
· Developed HPLC column packing materials such as 1.8 µm totally porous particles,
Dr. Jonathan EdelmanTao Jiang, Committee Member
Dr. Tao Jiang is an expert in HPLC, GC and LC/MS with more than 20 years of research experience in separation media, instrumentation and their applications in pharmaceutical field. Currently she is a technical fellow in R&D at Mallinckrodt Pharmaceuticals. Dr. Jiang has published 23 papers, two book chapters, and 34 patents/patent applications; she has delivered more than 50 conference presentations. She received her M.S. in Organic
Aihua Liu, Committee Member
Dr. Aihua Liu is the Executive Director of Bioanalysis at Resolian. She holds a Ph.D. in Analytical Chemistry, an M.S. in Pharmaceutical Chemistry, and a B.S. in Pharmacy. Prior to joining Resolian, Dr. Liu held senior leadership positions at Alliance Pharma, Dyad Labs and Covance/LabCorp/Tandem Labs. With over two decades of experience in regulated bioanalysis, Dr. Liu is a recognized expert in the development, validation, and execution of innovative bioanalytical methods. Her expertise spans oligonucleotides, antibody-drug conjugates (ADCs), proteins, biomarkers, chiral compounds, lipids, small molecules, and emerging modalities. She has authored more than 90 scientific contributions, including conference posters, oral presentations, peer-reviewed publications, and book chapters. Beyond her scientific accomplishments.
Dujuan Lu, Committee Member
Dr. Dujuan Lu serves as the head of the extractables and leachables (E&L) team at the SGS Health Science since 2015 and has been in the E&L industry since 2011. As a subject matter expert in the E&L field, she is frequently presenting at various conferences (AAPS, CPhI, E&L USA, E&L Summit, Pittcon, ASMS, etc.) as invited speakers and technical session chairs. Dr. Lu obtained her PhD in analytical chemistry under Professor Stephen Weber from the University of Pittsburgh and BS in chemistry from Nanjing University.
Chuping Luo, Committee Member
Dr. Chuping Luo is the Senior Research Scientist in Advanced Materials Technology. His interests includes developing new chromatographic stationary phases and application methods for bio-separation and small molecules.
From 2010 to 2015, Dr. Luo was the Principal Scientist in Waters Corporation, where he developed many critical methods in solving the applications in Supercritical Fluid Chromatography
Perry G. Wang, Committee Member
Dr. Perry G. Wang is a chemist in the Office of Regulatory Science, US Food and Drug Administration (US FDA). His interests include analytical method development and validation for drugs and constituents of foods and cosmetic products using advanced instrumentation. His expertise focuses on high throughput drug analysis by LC/MS/MS. His current research focuses on developing analytical methods for constituents in cosmetics and dietary supplements by GC/MS/MS and LC/MS/MS.
Dr. Bingchuan WeiNaidong Weng, Committee Member
Dr. Weng is Scientific Director, Janssen Fellow, and Head of East Coast Bioanalytical Chemistry and Pharmacokinetics, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. In addition to support various programs at Janssen, current research interests of his group include novel bioanalytical quantitation for biomarkers, protein/peptides, and novel drug conjugates and unique formulations. Dr. Weng has over 100 peer-reviewed journal publications,
Dr. Baoming Xin
Dr. Yanbo YangMichael Ye, Committee Member
M
Dr. Michael Ye is the R&D Manager of Liquid Separation Department in Supelco, a division of Sigma-Aldrich. He has over 20 years experience in chromatographic analysis and separation including over 10 years experience in separation product research and development. He received his bachelor's degree from the Department of Chemistry, Lanzhou University and Ph.D. from the Institute of Chemistry, Chinese Academy of Science, Beijing, China. He has a MBA degree from Colorado State University.
Xiang Zhang, Committee Member
Dr. Zhang received his B.S. from Lanzhou University, China and his M.S. from the Institute of Modern Physics, Chinese Academy of Sciences. He joined Purdue University in 1996, and worked in Dr. Fred E. Regnier’s laboratory. After receiving his Ph.D. degree in 2001, Dr. Zhang joined Beyond Genomics, Inc., a systems biology company in Boston, to develop bioanalytical and bioinformatics platforms for disease biomarker discovery and validation. In 2004, Dr. Zhang returned to Purdue University as the Director of
Emmi Zheng, Committee Member
Emmi Zheng
Dr. Emmi Zheng received her B.S. in chemistry from Jilin University, and Ph.D. in analytical chemistry from Dr. David Hage’s research group at the University of Nebraska-Lincoln (UNL). Emmi is currently an R&D Scientist in the biotherapeutics product development group at Smith & Nephew. Emmi has ten year research experience in bioanalytical chemistry.